financetom
Business
financetom
/
Business
/
FMCG industry grows 12% in second quarter of FY23, volumes highest in eight quarters
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FMCG industry grows 12% in second quarter of FY23, volumes highest in eight quarters
Aug 10, 2023 8:45 AM

India’s fast-moving consumer goods (FMCG) industry grew 12.2 percent in value in the April-June quarter of 2023 driven by higher consumption growth, according to data from NIQ India (formerly NielsenIQ).

Share Market Live

NSE

The industry recorded a volume growth of 7.5 percent, the highest in the last eight quarters. Price growth came in at 4.4 percent, which is the lowest in at least nine quarters.

This comes after the FMCG industry saw high inflation translating into price-led growth for over two years. FMCG companies too, have indicated that price-led growth has started tapering off and volume-led growth is set to return in the next few quarters.

For the last quarter, the FMCG industry grew 10.2 percent year-on-year (YoY) in value last quarter, while volumes grew 3.1 percent. The industry saw price growth of 6.9 percent in the January-March quarter.

“Q2 of FY23, thus far, is the best quarter in a year and a half, with positive strides across all growth vectors we track. Recovery in rural markets which was in negative territory for the last few quarters, is primarily driven by non-food.

This combined with a 21 percent growth in Modern Trade augers well for the upcoming festive seasons,” Roosevelt D’Souza, Lead, Customer Success, NIQ India said in a statement.

Rural markets too, saw some recovery with volumes growing four percent YoY as compared to a flat growth of 0.3 percent last quarter and a degrowth of 2.4 percent in the same quarter last year. Urban markets continued momentum with consumption growth of 10.2 percent, which is double the 5.3 percent growth it saw last quarter.

From a category point of view, NIQ India says the Foods category saw volumes grow 8.5 percent in the quarter driven by staples and Impulse categories. It adds that consumers are leaning back towards Habit Forming categories in cities and metros.

Within the non-food categories, there is also an improvement to 5.4 percent in Q2 of FY23 (from 0.2 percent in Q1 of FY23). NIQ India attributes this to a revival in rural consumption growth (1.4 percent in Q2 of FY23 from -3.9 percent in Q1 of FY23), through the home care categories while personal care categories continue to see a decline in rural areas.

In the retail space, modern trade continues to see double-digit consumption growth (21.1 percent) while traditional trade sees an improvement to 6.2 percent in Q2 of FY23 from 1.9 percent in Q1 of FY23.

"The softening of India’s inflation rate and the decline in food inflation is good news for the industry. This has led to confidence in spending reflected in retail channels across the country that are growing”, said Satish Pillai, MD of NIQ India.

"Further, the overall drop in price growth driven by the food categories has also had a positive impact on consumers and is anticipated to be mirrored in the build-up to the festive season,” he added.

Also Read:ADF Foods aims to double its revenue every three years, says CMD

First Published:Aug 10, 2023 5:45 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MoonLake's SLK Showed Limited Effectivesness in Recent Trials, Impacting Sales, Commercial Outlook, RBC Says
MoonLake's SLK Showed Limited Effectivesness in Recent Trials, Impacting Sales, Commercial Outlook, RBC Says
Sep 29, 2025
11:31 AM EDT, 09/29/2025 (MT Newswires) -- MoonLake Immunotherapeutics' ( MLTX ) SLK showed limited effectiveness in treating hidradenitis suppurativa which is likely to impact its sales and potential in other competitive markets like psoriatic arthritis, RBC Capital Markets said in a note Monday. SLK's phase 3 trial in hidradenitis suppurativa produced mixed results, with one study reaching statistical significance...
Beyond Oil Announces First Distribution Agreement in Vietnam
Beyond Oil Announces First Distribution Agreement in Vietnam
Sep 29, 2025
11:59 AM EDT, 09/29/2025 (MT Newswires) -- Beyond Oil ( BEOLF ) Monday announced its entry into the Vietnamese market through a new distribution agreement with Trang Anh Manufacturing and Trading. The distribution agreement, dated Sept. 26, 2025, marks Beyond Oil's ( BEOLF ) first commercial presence in Vietnam. It has an initial term of five years and requires the...
LGI Homes Foreclosure Rates 4x Higher Than FHA Average, Hunterbrook Report Alleges
LGI Homes Foreclosure Rates 4x Higher Than FHA Average, Hunterbrook Report Alleges
Sep 29, 2025
Shares of homebuilder LGI Homes Inc ( LGIH ) are trading lower Monday morning after a report by Hunterbrook Media accused the company of luring renters into buying homes they cannot afford through deceptive marketing and aggressive sales tactics. What To Know: The report, titled “Buyer’s Remorse,” alleges LGI Homes ( LGIH ) targets low-income individuals with ads for unrealistically...
Genmab's $8 Billion Bid Represents 'Good Deal' for Merus' Petosemtamab, Truist Says
Genmab's $8 Billion Bid Represents 'Good Deal' for Merus' Petosemtamab, Truist Says
Sep 29, 2025
11:38 AM EDT, 09/29/2025 (MT Newswires) -- Genmab's ( GMAB ) $8 billion offer for Merus (MRUS) represents a good deal that largely reflects the value of Merus' petosemtamab as a treatment for head and neck cancer, Truist Securities said in a Monday note. The all-cash transaction was announced earlier today, under which a Genmab ( GMAB ) unit will...
Copyright 2023-2026 - www.financetom.com All Rights Reserved